{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:56:06Z","timestamp":1781920566490,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Union\u2019s Seventh Programme for research, technological development and demonstration","award":["602272"],"award-info":[{"award-number":["602272"]}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["P3-0296"],"award-info":[{"award-number":["P3-0296"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ticks and Tick-borne Diseases"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ttbdis.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T19:15:39Z","timestamp":1535656539000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia"],"prefix":"10.1016","volume":"10","author":[{"given":"J.","family":"Mihajlovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.R.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sprong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bogovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ttbdis.2018.08.014_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116767","article-title":"Health care costs, utilization and patterns of care following Lyme disease","volume":"10","author":"Adrion","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0010","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1016\/j.vaccine.2015.07.030","article-title":"Tick-borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden","volume":"33","author":"Askling","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0015","series-title":"in Slovenian]. Sekcija za protimikrobno zdravljenje SZD, Klinika za infekcijske bolezni in vro\u010dinska stanja UKCL","first-page":"92","article-title":"Novosti V Infektologiji","author":"Bogovi\u010d","year":"2012"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.12998\/wjcc.v3.i5.430","article-title":"Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management","volume":"3","author":"Bogovic","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/841027","article-title":"Quantitative evaluation of the severity of acute illness in adult patients with tick-borne encephalitis","author":"Bogovic","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0030","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1016\/j.vaccine.2010.02.026","article-title":"A systematic review of national immunization policy making processes","volume":"28S","author":"Bryson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0040","unstructured":"Data available at Lyme Borreliossis Outpatient Clinic (LBOC) of University Medical Centre of Ljubljana, 2018. Personal Communication."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0045","series-title":"Expert Consultation on Tick Borne Diseases with Emphasis on Lyme Borreliosis and Tick-borne Encephalitis","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2011"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0050","series-title":"Epidemiological Situation of Tick-borne Encephalitis in the European Union and European Free Trade Association Countries, 2012","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2012"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0055","series-title":"Annual Epidemiological Report, Emerging and Vector-borne Diseases","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2014"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0060","series-title":"Annual Epidemiological Report, Emerging and Vector-borne Diseases","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2016"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0065","doi-asserted-by":"crossref","first-page":"30509","DOI":"10.2807\/1560-7917.ES.2017.22.16.30509","article-title":"Estimating the annual burden of tick-borne encephalitis to inform vaccination policy, Slovenia, 2009 to 2013","volume":"22","author":"Fafangel","year":"2017","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0070","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1016\/j.vaccine.2011.05.033","article-title":"High burden of tick-borne encephalitis in Slovenia--challenge for vaccination policy","volume":"29","author":"Grgi\u010d-Vitek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0075","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/art.10270","article-title":"Cost-effectiveness analysis of the Lyme disease vaccine","volume":"46","author":"Hsia","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0085","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1016\/j.vaccine.2015.06.084","article-title":"Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review","volume":"33","author":"Jit","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0090","unstructured":"J\u00fcrisson M., Taba P., V\u00f5rno T., Abram M., Eiche I.-E., Uusk\u00fcla A., 2015. Puukentsefaliidivastase vaktsineerimise kulut\u00f5husus Eestis. Tartu: Tartu \u00dclikooli tervishoiu instituut[in Finish]. Summary available in English: The cost-effectiveness of tick-borne encephalitis vaccination in Estonia. Available at: http:\/\/rahvatervis.ut.ee\/bitstream\/1\/6065\/2\/TTH13_Tick-borne_encephalitis_vaccination_summary.pdf (Accessed 20 April 2018)."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0095","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0100","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00508-006-0699-6","article-title":"Tick-borne encephalitis in Slovenia from 2000 to 2004: comparison of the course in adult and elderly patients","volume":"118","author":"Logar","year":"2006","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3201\/eid0503.990302","article-title":"The cost effectiveness of vaccinating against Lyme disease","volume":"5","author":"Meltzer","year":"1999","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0110","doi-asserted-by":"crossref","first-page":"s253","DOI":"10.1093\/cid\/ciq116","article-title":"Vaccines against Lyme disease: what happened and what lessons can we learn?","volume":"52","author":"Poland","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0115","series-title":"R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing","author":"R Development Core Team","year":"2008"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.zefq.2014.08.019","article-title":"Health economic evaluation in England","volume":"108","author":"Raftery","year":"2014","journal-title":"Z. Evid. Fortbild. Qual."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2014.09.023","article-title":"Comparison of NITAG policies and working processes in selected developed countries","volume":"33","author":"Ricciardi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0130","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.2807\/ese.16.27.19906-en","article-title":"Lyme borreliosis in Europe","volume":"16","author":"Rizzoli","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archinte.161.4.554","article-title":"The cost-effectiveness of vaccination against Lyme disease","volume":"161","author":"Shadick","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0140","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1016\/j.vaccine.2012.07.083","article-title":"Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults","volume":"30","author":"\u0160mit","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144988","article-title":"The burden of tick-borne encephalitis in disability-adjusted life years (DALYs) for Slovenia","volume":"10","author":"\u0160mit","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1756-3305-7-77","article-title":"ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe","volume":"7","author":"Sprong","year":"2014","journal-title":"Parasite Vectr."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0160","series-title":"Population Data","author":"Statistical office of the Republic of Slovenia","year":"2018"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0165","series-title":"Economic Data","author":"Statistical office of the Republic of Slovenia","year":"2018"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ttbdis.2010.10.007","article-title":"Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia\u2014an overview","volume":"2","author":"S\u00fcss","year":"2011","journal-title":"Ticks. Tick-borne. Dis."},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0175","series-title":"Epidemiological Surveillance of Communicable Diseases in Slovenia","author":"The National Public Health Institute of the Republic Slovenia","year":"2018"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0180","series-title":"Uradni List Republike Slovenije, 2013. Pravilnik O Razvr\u010danju Zdravil Na Listo, \u0160t.35\/2013, 26\/4\/2013","year":"2013"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0185","series-title":"Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission","author":"WHO Commission on Macroeconomics and Health","year":"2001"},{"key":"10.1016\/j.ttbdis.2018.08.014_bib0190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1473-3099(13)70110-5","article-title":"Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1\/2 trial","volume":"13","author":"Wressnigg","year":"2013","journal-title":"Lancet Infect. Dis."}],"container-title":["Ticks and Tick-borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X18301730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X18301730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T23:40:31Z","timestamp":1661902831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877959X18301730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1877959X18301730"],"URL":"https:\/\/doi.org\/10.1016\/j.ttbdis.2018.08.014","relation":{},"ISSN":["1877-959X"],"issn-type":[{"value":"1877-959X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia","name":"articletitle","label":"Article Title"},{"value":"Ticks and Tick-borne Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ttbdis.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}